3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
58
Filgrastim
37
Radiotherapy
31
Busulfan
28
fludarabine phosphate
26
Antilymphocyte Serum
25
Cyclosporine
24
Peripheral Blood Stem Cell Transplantation
23
Etoposide
22
Methotrexate
20
Melphalan
18
Mycophenolic Acid
17
Cord Blood Stem Cell Transplantation
17
Methylprednisolone
16
Vincristine
13
Cytarabine
13
Tacrolimus
12
Rituximab
11
Whole-Body Irradiation
9
Thiotepa
9
Prednisone
9
Doxorubicin
8
Leucovorin
7
sargramostim
6
aldesleukin
6
Granulocyte Colony-Stimulating Factor
6
Psychiatric Rehabilitation
5
Daunorubicin
5
pembrolizumab
4
Sirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Referral and Consultation
×
Sarcoma
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts